Midsize Pharmaceutical Firms Are the Industry’s Big Deal Makers

Typically the biggest drugmakers do the most deals by value. Yet large-cap pharmaceutical companies have pulled back on acquisitions this year, as they pay down debt from previous sprees and resist high premiums.

Apple, Amazon, Tesla Set to Post Results

More than a third of the S&P 500—including McDonald’s, Ford and...

Social-Media Manager, the Most Millennial Job, Comes of Age

Some social-media veterans have been doing their jobs for 15 years...

Chicago Casino Would Be Costly, Gambling Operators Say

Chicago is hoping a megacasino will aid its underfunded pensions but...

The Boss Wants You Back in the Office. Like, Now.

Companies are starting to summon workers back, though many employees have...